Pharmaceutical: Tamsulosin (36C77024Q0292)
Expired
Key information
- Agency Name
- Department of Veterans Affairs
- Waiver Type
- Non-availability
- Procurement Stage
- Post-solicitation
- OMB Determination
- Approved
- Product Service Code (PSC)
- 6505 - DRUGS AND BIOLOGICALS
Waiver Details
Waiver Coverage
Individual Waiver
Summary of Procurement
VHA RPO-C/CMOP intends to procure Tamsulosin HCL for VA CMOPs. This procurement was solicited via 36C77024Q0292 as a competitive SDVOSB set-aside. This procurement is not subject to the Trade Agreements Act due to it being set aside for SDVOSBs. Tamsulosin HCL is an alpha1 adrenoceptor antagonist indicated for treatment of the signs and symptoms of benign prostatic hyperplasia. This prescription is supplied to the CMOP, which provides direct mail order pharmacy services to Veterans and beneficiaries throughout the U.S. This is a onetime purchase with monthly deliveries for six (6) months.
Was a sources sought or Request for Information issued?
No
Submitted
11/04/2024
Determination Date
11/06/2024
| Product Name | North American Industry Classification System (NAICS) | Product Service Code (PSC) | Quantity |
|---|---|---|---|
| Pharmaceutical: Tamsulosin (36C77024Q0292) | 325412 - Pharmaceutical Preparation Manufacturing | 6505 - DRUGS AND BIOLOGICALS |
Procurement Instrument Identifier(s) (PIID) for this waiver (if applicable)
36C77024Q0292
Solicitation ID(s)
36C77024Q0292
Dates
Waiver Start Date
11/06/2024
Waiver Expiration Date
05/05/2025